XyloCor Therapeutics

XyloCor Therapeutics is a gene therapy company focused on improving the lives of people with cardiovascular disease. The company's proprietary products address significant unmet needs in this field, with a pipeline of novel gene therapies developed in partnership with Weill Cornell Medical College. XyloCor is committed to advancing the science of gene therapy and delivering innovative solutions to patients.